The USMLE (United States Medical Licensing Examination) is the three-step gauntlet every physician needs to clear before practicing medicine in the US. The big question candidates ask is simple: what is a good score, and what counts as passing? The answer changed in January 2022, when Step 1 moved to pass/fail reporting, leaving Step 2 CK and Step 3 as the only numerically scored components.
That single shift rewired how program directors evaluate applicants, and it pushed the focus toward Step 2 CK percentiles, clinical rotations, and research output. Whether you're an M1 mapping out the next four years or an applicant prepping for ERAS submission, knowing how scores translate into match outcomes is non-negotiable.
So what is USMLE in practical terms? It's a licensing exam co-sponsored by the FSMB and NBME, not a ranking tool β but residency programs still use the numeric scores they can see to filter thousands of applications. Knowing the current usmle step 2 score averages, the usmle step 3 passing score, and the historical usmle step 1 passing score (still relevant for repeat takers and IMGs) helps you set realistic targets.
This guide breaks down each step's format, the percentiles attached to common scores, and how match data correlates with numeric performance. We'll also cover question counts, timing, retake limits, and the score-improvement habits that move applicants from the 50th percentile to the 90th.
The data is current as of the 2026 application cycle. Score distributions, mean scores, and pass rates are updated based on the most recent USMLE Performance Data and NRMP Charting Outcomes in the Match. While exact percentiles shift slightly year to year, the general framework β Step 1 as pass/fail gateway, Step 2 CK as the differentiating numeric score, Step 3 as a confidence check during intern year β has remained stable since the 2022 transition.
The numbers above tell a quick story. The pass rate of usmle step 1 sits high for first-time US MD examinees (around 95% pre-2022, with similar trends post-transition), but that figure drops sharply for IMGs and repeaters, where the pass rate usmle step 1 can fall below 75% in some cohorts.
Step 2 CK is where the modern numeric battle plays out: with a mean near 245 and a standard deviation around 16, a score of 260 lands you near the 80th percentile, and 270 puts you above the 90th. Step 3 is the most forgiving β most candidates clear it on the first attempt because they take it during intern year, when clinical reasoning is sharp and patient management is part of daily routine.
Why does this matter? Because residency match data shows a tight correlation between Step 2 CK scores and match probability for competitive specialties. Dermatology, plastic surgery, orthopedics, and otolaryngology applicants who match typically post Step 2 CK scores in the 250β265 range. Internal medicine and family medicine matches happen across a wider spread, with successful candidates passing in the 230β245 zone. The numeric Step 2 CK score is now doing the heavy lifting that Step 1 used to do, and program directors increasingly use both the raw three-digit score and the percentile rank when filtering applications.
Pass rates also vary significantly by school type and prep timing. US MD seniors taking Step 1 within their normal preclinical sequence have the highest first-attempt pass rates. DO students who complete COMLEX alongside USMLE often pass at similar rates. IMGs, including US-IMGs and non-US-IMGs, face tougher odds β language barriers, clinical exposure gaps, and inconsistent curriculum quality drag pass rates down.
Repeat takers across all groups see substantially lower pass rates than first-attempters, which is why making your first attempt count matters so much. The cost of a retake isn't just the exam fee β it's the lost months, the psychological hit, and the red flag on your residency application that program directors notice immediately.
Step 2 CK score distributions show the same pattern with a slightly steeper curve. The 245 mean reflects US MD first-time takers; the equivalent figure for IMGs typically lands 10β15 points lower. Standard deviation around 16 means roughly 68% of scores fall between 229 and 261, and 95% sit between 213 and 277.
If you're scoring at the mean, you're competitive for non-competitive specialties at most programs. Anything above 260 places you in the top quintile and opens doors at academic centers. A 275+ score is rare enough to draw attention even at highly selective programs, though it never substitutes for research, letters, and clinical evaluations.
With Step 1 reporting only Pass/Fail, program directors lean heavily on Step 2 CK percentiles to differentiate applicants. A 250+ Step 2 CK score is the new equivalent of a 240+ Step 1 score from the pre-2022 era. Aim for above the mean (245) at minimum; aim for 260+ if you're targeting competitive specialties or top-tier programs.
Each step tests a different layer of medical knowledge, and the format reflects that. Step 1 covers basic sciences β biochemistry, pharmacology, microbiology, pathology, physiology, immunology, and behavioral science β and asks you to apply them to clinical vignettes. Step 2 Clinical Knowledge (CK) pivots fully to clinical reasoning, diagnosis, and management across all major medical disciplines.
Step 3 closes the loop with a two-day exam that mixes multiple-choice questions and computer-based case simulations (CCS), testing whether you can manage patients independently. The hours, question counts, and pacing differ across all three, and underestimating that workload is the single biggest reason candidates underperform.
Many applicants ask how many questions on usmle step 1 there are, and the answer surprises people: 280 questions split across seven 60-minute blocks, with 40 questions per block. That's a long day. How many questions usmle step 1 queries also tie to pacing strategy β you get roughly 90 seconds per question, which sounds generous until you hit a multi-paragraph vignette with a complex pedigree chart, an interpretation-heavy ECG, or a multi-step pharmacology calculation.
Step 2 CK is longer (318 questions, nine hours), and Step 3 stretches across two separate test days totaling roughly 16 hours of seat time. The pacing burden on Step 2 CK is even tighter than Step 1 in practice β clinical vignettes tend to be denser, with more lab values, imaging, and management options to weigh.
Test-day logistics matter more than most candidates realize. You can break between blocks, but total break time is capped at 45 minutes for Step 1 and Step 2 CK. Skip the tutorial at the start of the exam (you've seen it in your NBMEs) to bank an extra 15 minutes of break time. Eat protein-heavy snacks, hydrate without overdoing it, and keep your post-break routine identical to what you practiced in mock exams.
Stamina is a skill β train it deliberately or it will fail you in the last two blocks when fatigue compounds and reading comprehension drops. Schedule your test on a day of the week when you historically perform well in practice; many candidates avoid Mondays and Fridays for this reason.
Step 3 deserves separate planning because it spans two days. Day 1, called Foundations of Independent Practice (FIP), contains 232 multiple-choice questions across six 60-minute blocks. Day 2, the Advanced Clinical Medicine (ACM) section, mixes 180 MCQs with 13 CCS cases. You schedule both days within a 14-day window, with most candidates taking them back-to-back or with a single rest day between.
The CCS portion is the trickiest part β it's interactive, with no preset answers, and you have to decide what to order, when to advance time, and when to discharge. Practicing CCS through UWorld's simulator or the free NBME tutorial is mandatory if you want to avoid panicking on test day.
7 blocks, 60 minutes each. Total seat time: 8 hours including breaks. Pass/Fail since Jan 2022. Basic sciences focus: pathology, pharmacology, biochemistry, physiology, microbiology, immunology, behavioral science.
8 blocks, 60 minutes each. Total seat time: 9 hours. Three-digit numeric score (passing 214, mean ~245). Clinical knowledge focus: diagnosis, prognosis, mechanisms of disease, management, health maintenance.
Two-day exam. Day 1 (FIP): 232 MCQs across 6 blocks, ~7 hours. Day 2 (ACM): 180 MCQs + 13 CCS cases, ~9 hours. Three-digit score (passing 198). Tests independent clinical practice readiness.
Scoring on the USMLE is more nuanced than a simple percentage. Step 2 CK and Step 3 use a three-digit scaled score that compresses raw performance through an equating process so that scores remain comparable across years and test forms. A 240 in 2018 means roughly the same level of mastery as a 240 in 2026, even if the specific questions differ.
USMLE step 2 ck scores are reported alongside a percentile that shows where you fall against the testing cohort over a recent window (usually three years). Those usmle step 2 percentiles matter for residency applications because program directors often filter by both raw score and percentile band β a 250 today doesn't sit at the same percentile as a 250 from a decade ago, since the test population shifts over time.
For Step 1, the move to Pass/Fail eliminated the score report entirely. You get a single status update, and if you fail, you receive a performance breakdown by content area to help with retakes. That change was driven by concerns about score inflation, mental health pressure on first-year students, and the use of Step 1 as a residency screening tool when it was designed to verify minimum competence.
Whether the change achieved those goals is debated β most program directors say the focus simply shifted to Step 2 CK, and IMG applicants in particular feel they've lost a critical objective metric for demonstrating equivalence with US graduates.
The usmle step 1 passing score historically was 194 on the three-digit scale, but since January 2022 the exam reports only Pass or Fail. The usmle step 1 pass rate for US/Canadian MD first-time takers hovers near 95%, with DO students close behind. IMG and repeat-taker rates run lower. The Pass/Fail shift means Step 1 no longer differentiates applicants competitively β it's a gateway exam. Program directors now use Step 2 CK as the primary numeric screen, alongside clinical grades, research, and letters of recommendation. The passing rate of usmle step 1 matters more for IMG applicants whose home-school grading systems are harder to interpret.
Step 2 CK scoring uses the same three-digit scale as Step 3. The passing score is 214; the mean for US MD first-time takers is approximately 245 with a standard deviation around 16. Percentile benchmarks: 230 = ~25th percentile, 245 = ~50th (median), 255 = ~70th, 260 = ~80th, 265 = ~85th, 270 = ~90th, 275 = ~95th. A usmle step 2 score percentile in the 80β90 range is the soft target for competitive specialties like dermatology, neurosurgery, orthopedics, and plastic surgery. Mid-tier specialties (general surgery, anesthesiology, OB/GYN) typically match candidates in the 240β255 band.
The usmle step 3 score uses the same three-digit scale, with a passing score of 198 β slightly lower than Step 2 CK because the exam tests applied clinical practice rather than knowledge breadth. Mean scores fall around 226 with a standard deviation near 15. Step 3 is typically taken during intern year (PGY-1), and the pass rate is approximately 98% for US MD graduates on the first attempt. The CCS (Computer-based Case Simulations) component tests interactive patient management β you order tests, prescribe treatments, and watch outcomes evolve. While Step 3 scores are not typically used for fellowship applications, exceptional or borderline scores can influence subspecialty matching.
NRMP and Match data consistently show that higher Step 2 CK scores correlate with higher match probabilities across all specialties. For competitive specialties (derm, plastics, ortho, ENT, neurosurg), matched US MD seniors average Step 2 CK scores of 255β265. For internal medicine and family medicine, matched applicants typically score 235β250. Unmatched applicants average 10β15 points lower than matched peers across most specialties. However, score is one input among many: research output, away rotations, letters of recommendation, AOA membership, and interview performance all factor in. A 270 with no research is not equivalent to a 250 with multiple publications for academic programs.
If your score isn't where you want it, the strategy depends on which step you're targeting and how much runway you have. The biggest mistake test-takers make is over-relying on passive resources β re-reading First Aid or watching lecture videos without actively retrieving information. Spaced repetition through Anki, daily UWorld blocks, and timed practice exams build the retrieval strength that actually shows up on test day. The second mistake is ignoring weaknesses: candidates gravitate toward topics they already know because it feels productive, but score gains come from attacking the lowest-performing subjects first. Painful subjects are where the points hide.
A realistic timeline matters too. Most successful Step 1 prep cycles run 6β8 weeks of dedicated study after a strong M2 year. Step 2 CK candidates often allot 4β6 weeks of dedicated time, ideally late in third year or early fourth year while clinical rotations are still fresh.
Step 3 is unique β you study during intern year with limited time, so frontloading UWorld questions before residency starts is the smart move. The strategies below work across all three steps if you commit to them consistently. Don't try every tactic at once; pick three or four, integrate them for two weeks, then assess whether your NBME scores are climbing before adding more.
The following checklist captures the score-improvement tactics that produce the largest score bumps per hour invested. None of them are exotic β they're the discipline habits that separate 220 scorers from 250 scorers from 270 scorers. Pick the items you're not already doing and integrate them into your weekly schedule. Track your performance with NBME assessments every 2β3 weeks so you can quantify whether your strategy is working or whether you need to pivot. If your NBME average is stuck, change something β don't just grind harder on the same approach.
The Pass/Fail change for Step 1 was the biggest shake-up in USMLE history, and the debate over whether it helped or hurt applicants continues. Supporters argue it reduced student burnout and let medical schools refocus first and second years on integrated learning rather than test prep. Critics counter that it just transferred the same pressure to Step 2 CK, where candidates now grind even harder, and disadvantaged IMG applicants who lost their main objective metric for distinguishing themselves.
The truth sits somewhere in the middle. Below is a clear pros-and-cons breakdown for applicants navigating the new landscape β useful whether you're an M1 deciding how aggressively to chase Step 1 prep or a residency hopeful weighing whether to delay Step 2 CK for more prep time.
So how should you think about your USMLE strategy in 2026 and beyond? Treat Step 1 as a competence exam β pass it on the first attempt, don't burn out chasing arbitrary thresholds, and reserve your peak study energy for Step 2 CK.
Schedule Step 2 CK strategically so your score is back in time for residency applications (typically JuneβJuly of the application year, since ERAS opens in September and scores need to be uploaded before program directors begin filtering). For Step 3, knock it out early in intern year while UWorld habits are still strong; a strong Step 3 score is a small but real differentiator for academic fellowships and visa applicants who need to demonstrate clinical readiness beyond their training pathway.
Above all, don't let percentile obsession derail your clinical learning. Program directors are increasingly clear that they want well-rounded applicants: solid scores, meaningful research, glowing letters, and evidence of professionalism. A 270 Step 2 CK with no research and lukewarm clinical evaluations is a weaker application than a 250 with two first-author publications, strong sub-internship letters, and demonstrated commitment to a specialty. Use the numeric score as a foundation, not a finish line.
The applicants who match into their top-three programs almost always pair a competitive score with a coherent story about why they want this specialty and what they've done to prove it. Build that narrative deliberately from M1 onwards through research involvement, mentor relationships, away rotations, and student leadership β the score is necessary but never sufficient on its own. Treat your USMLE journey as one chapter in a longer professional story, not as the entire book.
The questions below come up constantly in forums, study groups, and Reddit threads. They cover the specifics that matter most when planning your test timeline, interpreting score reports, and deciding whether to retake. If you're early in the process and still asking what is usmle at a basic level, the short answer is: it's a three-step exam that determines US medical licensure eligibility, taken across medical school and intern year, co-sponsored by the Federation of State Medical Boards and the National Board of Medical Examiners.
The longer answer β and the answers to the most common follow-ups about scoring, retakes, and timing β sits below. If you don't see your specific scenario covered, the official USMLE bulletin and your medical school's student affairs office are the authoritative resources for edge cases like accommodations, eligibility extensions, and inter-step timing requirements.